• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

    7/1/22 4:31:01 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CGC alert in real time by email
    SC 13D/A 1 d169036dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 7)

     

     

    Canopy Growth Corporation

    (Name of Issuer)

    Common Shares, no par value

    (Title of Class of Securities)

    901164

    (CUSIP Number)

    Lloyd H. Spencer, Esq.

    Nixon Peabody LLP

    799 9th Street NW, Suite 500

    Washington, D.C. 20001

    (202) 585-8000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    June 29, 2022

    (Date of Event which Requires Filing of this Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ☐.

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 901164    SCHEDULE 13D    Page 2 of 19

     

      1     

    NAME OF REPORTING PERSONS

     

    Greenstar Canada Investment Limited Partnership

      2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  ☒        (b)  ☐

     

      3  

    SEC USE ONLY

     

      4  

    SOURCE OF FUNDS

     

    OO

      5  

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

    ☐

      6  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    British Columbia

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7      

    SOLE VOTING POWER

     

    0

         8   

    SHARED VOTING POWER

     

    59,683,716

         9   

    SOLE DISPOSITIVE POWER

     

    0

       10   

    SHARED DISPOSITIVE POWER

     

    59,683,716

    11    

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    59,683,716

    12  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

    ☒

    13  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    13.0%

    14  

    TYPE OF REPORTING PERSON

     

    PN


    CUSIP No. 901164    SCHEDULE 13D    Page 3 of 19

     

      1     

    NAME OF REPORTING PERSONS

     

    Greenstar Canada Investment Corporation

      2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  ☒        (b)  ☐

     

      3  

    SEC USE ONLY

     

      4  

    SOURCE OF FUNDS

     

    OO

      5  

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

    ☐

      6  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    British Columbia

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7      

    SOLE VOTING POWER

     

    0

         8   

    SHARED VOTING POWER

     

    59,683,716

         9   

    SOLE DISPOSITIVE POWER

     

    0

       10   

    SHARED DISPOSITIVE POWER

     

    59,683,716

    11    

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    59,683,716

    12  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

    ☒

    13  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    13.0%

    14  

    TYPE OF REPORTING PERSON

     

    CO


    CUSIP No. 901164    SCHEDULE 13D    Page 4 of 19

     

      1     

    NAME OF REPORTING PERSONS

     

    Constellation Brands Canada Holdings ULC

      2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  ☒        (b)  ☐

     

      3  

    SEC USE ONLY

     

      4  

    SOURCE OF FUNDS

     

    OO

      5  

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

    ☐

      6  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Nova Scotia

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7      

    SOLE VOTING POWER

     

    0

         8   

    SHARED VOTING POWER

     

    59,683,716

         9   

    SOLE DISPOSITIVE POWER

     

    0

       10   

    SHARED DISPOSITIVE POWER

     

    59,683,716

    11    

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    59,683,716

    12  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

    ☒

    13  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    13.0%

    14  

    TYPE OF REPORTING PERSON

     

    HC and CO


    CUSIP No. 901164    SCHEDULE 13D    Page 5 of 19

     

      1     

    NAME OF REPORTING PERSONS

     

    Constellation Capital LLC

      2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  ☒        (b)  ☐

     

      3  

    SEC USE ONLY

     

      4  

    SOURCE OF FUNDS

     

    OO

      5  

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

    ☐

      6  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7      

    SOLE VOTING POWER

     

    0

         8   

    SHARED VOTING POWER

     

    59,683,716

         9   

    SOLE DISPOSITIVE POWER

     

    0

       10   

    SHARED DISPOSITIVE POWER

     

    59,683,716

    11    

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    59,683,716

    12  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

    ☒

    13  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    13.0%

    14  

    TYPE OF REPORTING PERSON

     

    HC and CO


    CUSIP No. 901164    SCHEDULE 13D    Page 6 of 19

     

      1     

    NAME OF REPORTING PERSONS

     

    Constellation International Holdings Limited

      2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  ☒        (b)  ☐

     

      3  

    SEC USE ONLY

     

      4  

    SOURCE OF FUNDS

     

    OO

      5  

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

    ☐

      6  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    New York

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7      

    SOLE VOTING POWER

     

    0

         8   

    SHARED VOTING POWER

     

    59,683,716

         9   

    SOLE DISPOSITIVE POWER

     

    0

       10   

    SHARED DISPOSITIVE POWER

     

    59,683,716

    11    

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    59,683,716

    12  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

    ☒

    13  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    13.0%

    14  

    TYPE OF REPORTING PERSON

     

    HC and CO


    CUSIP No. 901164    SCHEDULE 13D    Page 7 of 19

     

      1     

    NAME OF REPORTING PERSONS

     

    Constellation Brands, Inc.

      2  

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)  ☒        (b)  ☐

     

      3  

    SEC USE ONLY

     

      4  

    SOURCE OF FUNDS

     

    OO

      5  

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

     

    ☐

      6  

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

      BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7      

    SOLE VOTING POWER

     

    0

         8   

    SHARED VOTING POWER

     

    303,929,169

         9   

    SOLE DISPOSITIVE POWER

     

    0

       10   

    SHARED DISPOSITIVE POWER

     

    303,929,169

    11    

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    303,929,169

    12  

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

     

    ☒

    13  

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     

    50.7%

    14  

    TYPE OF REPORTING PERSON

     

    HC and CO


    This Amendment No. 7 (this “Amendment”) is being filed by Greenstar Canada Investment Limited Partnership (“Greenstar LP”), Greenstar Canada Investment Corporation (“GCIC”), Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited, and Constellation Brands, Inc. (“Constellation”) (collectively, the “Reporting Persons”), pursuant to Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

    This Amendment amends the Schedule 13D filed on July 17, 2018 by Greenstar LP, GCIC, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited and Constellation (the “Initial Schedule 13D”), as the Initial Schedule 13D was amended by (i) Amendment No. 1 filed on August 16, 2018 (the “First Amendment”), by the Reporting Persons and CBG Holdings LLC (“CBG”), (ii) Amendment No. 2 filed on November 2, 2018 (the “Second Amendment”) by CBG and Constellation, (iii) Amendment No. 3 filed on December 3, 2018 (the “Third Amendment”) by the Reporting Persons, (iv) Amendment No. 4 filed on July 3, 2019 (the “Fourth Amendment”) by the Reporting Persons and CBG; (v) Amendment No. 5 filed on May 4, 2020 (the “Fifth Amendment) by the Reporting Persons; and (vi) Amendment No. 6 filed on April 29, 2021 (the “Sixth Amendment” and together with the First Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment, the Fifth Amendment and the Initial Schedule 13D, the “Schedule 13D”) by the Reporting Persons, CBG, Greenstar II LLC (“GII”), and Greenstar II Holdings LLC (“GIIH”).

    Item 1. Security and Issuer.

    Item 1 of the Schedule 13D is hereby amended and restated in its entirety as follows:

    The title and class of equity securities to which this Amendment relates is the Common Shares, no par value (the “Common Shares”), of Canopy Growth Corporation, a company organized and existing under the laws of Canada (the “Issuer” or “Canopy”). The principal executive offices of the Issuer are located at 1 Hershey Drive, Smiths Falls, Ontario Canada, K7A 0A8.

    Item 2. Identity and Background.

    Paragraphs (a) – (c) of Item 2 of the Schedule 13D is hereby revised and supplemented with the following:

    (a) – (c)    Current information concerning the identity and background of each executive officer and director of CBG, GII, GIIH, GCIC, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited and Constellation is set forth on Annex A (collectively, the “Covered Persons”), attached hereto and incorporated herein by reference.

    Paragraphs (d) - (e) of Item 2 of the Schedule 13D is hereby revised and supplemented with the following:

    (d) – (e) None of the Reporting Persons or, to the best knowledge of Greenstar LP, any of the Covered Persons has, during the past five years, been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which he, she or it is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

    Item 3. Source and Amount of Funds or Other Consideration.

    Item 3 of the Schedule 13D is hereby revised and supplemented with the following:

    As described below in Item 4, Greenstar LP will exchange C$100 million principal amount of the Issuer’s 4.25% Convertible Senior Notes due 2023 (the “Notes”) for Common Shares of the Issuer.

     

    Page 8 of 19


    Item 4. Purpose of Transaction

    Item 4 of the Schedule 13D is hereby revised and supplemented with the following:

    Greenstar LP entered into an Exchange Agreement, dated June 29, 2022 (the “Exchange Agreement”), with Canopy, pursuant to which Greenstar LP agreed to exchange C$100 million principal amount of Notes for Common Shares of Canopy (other than in respect of accrued but unpaid interest which will be paid in cash). The final number of Common Shares issuable to Greenstar LP will be calculated based on the volume-weighted average trading price of the Common Shares on the Nasdaq Global Select Market for a 10-day period beginning on and including June 30, 2022 (the “Exchange Price”), provided that the Exchange Price will not be less than $2.50 (the “Low Exchange Price”) or more than $3.50 (the “High Exchange Price”). As the Exchange Price is not yet known, the actual number of Common Shares issuable to Greenstar LP pursuant to the Exchange Agreement is not yet known. However, assuming the Low Exchange Price and current exchange rates, Greenstar LP would receive an aggregate of 30,701,880 Common Shares, representing approximately 7.6% of the issued and outstanding Common Shares as of June 29, 2022. Assuming the High Exchange Price and current exchange rates, Greenstar LP would receive an aggregate of 21,929,914 Common Shares, representing approximately 5.4% of the issued outstanding Common Shares as of June 29, 2022.

    Following the completion of the exchange contemplated by the Exchange Agreement (including the issuance of additional Common Shares to all other exchanging holders of the Notes) Greenstar LP would hold 68,455,682 Common Shares (representing approximately 14.2% of the then issued and outstanding Common Shares) at the Low Exchange Price and 59,683,716 Common Shares (representing approximately 13.0% of the then issued and outstanding Common Shares) at the High Exchange Price.

    Greenstar LP will continue to hold C$100 million principal amount of Notes, however, the terms of the Notes were amended on June 29, 2022 to remove the conversion feature of the Notes by Canopy irrevocably surrendering its right to settle the conversion of any Note by the issuance of Common Shares or a combination of cash and Common Shares. As a result, the conversion of any Note after June 29, 2022 will be settled in cash.

    Except as set forth in this Amendment, the Reporting Persons have no present plans or proposals that relate to or would result in any of the actions described in Item 4(a) through (j) of Schedule 13D. The Reporting Persons may evaluate on a continuing basis their investment in the Issuer and expect that they may from time to time acquire or dispose of Common Shares or other securities of the Issuer. The Reporting Persons may purchase or sell Common Shares or exercise the warrants in the future, either on the open market or in private transactions, in each case, depending on a number of factors, including general market and economic conditions and other available investment opportunities. Depending on market conditions, general economic and industry conditions, the Issuer’s business and financial condition and/or other relevant factors, the Reporting Persons may develop other plans or intentions in the future relating to one or more of the actions described in Item 4(a) through (j) of Schedule 13D.

    Item 5. Interest in Securities of the Issuer

    Paragraphs (a) – (c) of Item 5 of the Schedule 13D is hereby revised and supplemented as follows:

    (a) – (c) Greenstar LP has direct beneficial ownership of 59,683,716 Common Shares (including the 21,929,914 Common Shares that will be issued to Greenstar LP upon closing of the exchange contemplated by the Exchange Agreement at the High Exchange Price), representing approximately 13.0% of the issued and outstanding Common Shares of the Issuer as of June 29, 2022, as provided to the Reporting Persons by the Issuer (plus (i) 21,929,914 Common Shares that will be issued to Greenstar LP upon closing of the exchange contemplated by the Exchange Agreement at the High Exchange Price, and (ii) 34,073,165 Common Shares that were issued to other holders of Notes that also entered into exchange agreements with the Issuer to exchange their Notes for Common Shares). To the extent Greenstar LP receives more than 21,929,914 Common Shares upon completion of the exchange contemplated by the Exchange Agreement and such additional Common Shares represents a material change, Greenstar LP and the other Reporting Persons will file an amendment to the Schedule 13D. GCIC is the general partner of Greenstar LP and is wholly-owned by Constellation Brands Canada Holdings ULC, which in turn is wholly-owned by Constellation Capital LLC, which in turn is wholly-owned by Constellation International Holdings Limited, which in turn is wholly-owned by Constellation.

    Except as set forth in the Schedule 13D, to the best knowledge of the Reporting Persons and other than

     

    Page 9 of 19


    as previously disclosed, the Covered Persons do not beneficially own any Common Shares as of June 30, 2022 other than Judy A. Schmeling, who holds 34,593 Common Shares which were acquired following the vesting of restricted stock units acquired as compensation for her position as a director of the Issuer, including 13,393 restricted stock units acquired on June 30, 2022, and restricted stock units convertible into 26,786 Common Shares, which were acquired on June 8, 2022 as compensation for her position as a director of the Issuer and that vest in two equal installments on September 30, 2022 and December 31, 2022. The Reporting Persons disclaim beneficial ownership of each Covered Person’s Common Shares and such Common Shares are excluded from the aggregate amounts reported by the Reporting Persons in this Amendment and Schedule 13D.

    Except as set forth herein, neither the Reporting Persons, nor to the best knowledge of the Reporting Persons, any of the Covered Persons, has engaged in any transaction involving any Common Shares during the 60-day period ended June 30, 2022 other than the grant of the restricted stock units to Ms. Schmeling on June 8, 2022 or the vesting of the restricted stock units granted to Ms. Schmeling on June 30, 2022.

    The aggregate percentage of Common Shares reported owned by the Reporting Persons is based upon 403,135,499 Common Shares outstanding, which is the total number of Common Shares outstanding as of June 29, 2022, as provided to the Reporting Persons by the Issuer, plus (i) in the case of Constellation 139,745,453 Common Shares underlying the warrants held by CBG that are exercisable within 60 days of the date hereof and are treated as issued and outstanding only for the purpose of computing the percentage ownership of the Reporting Persons pursuant to Rule 13d-3(1)(i) under the Exchange Act, and (ii) in the case of Greenstar LP, GCIC, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited and Constellation (A) 21,929,914 Common Shares that will be issued to Greenstar LP upon closing of the exchange contemplated by the Exchange Agreement at the High Exchange Price and are treated as issued and outstanding only for the purpose of computing the percentage ownership of the Reporting Persons pursuant to Rule 13d-3(1)(i) under the Exchange Act, and (B) 34,073,165 Common Shares that were issued to other holders of Notes that also entered into exchange agreements with the Issuer to exchange their Notes for Common Shares.

    Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

    Item 6 of the Schedule 13D is hereby revised and supplemented as follows:

    In connection with the transactions described in Item 4 above, Greenstar LP and the Issuer entered into the Exchange Agreement (which is described in Item 4) on June 29, 2022. Other than as described in this Amendment and the Schedule 13D, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Persons and any other person with respect to any securities, including the Common Shares.

    Item 7. Material to Be Filed as Exhibits

     

    Exhibit 99.1    Joint Filing Agreement among the Reporting Persons dated July 1, 2022.
    Exhibit 99.2    Exchange Agreement, dated June 29, 2022, between Greenstar Canada Investment Limited Partnership and Canopy GrowthCorporation.

     

    Page 10 of 19


    Signature

    After reasonable inquiry and to the best of the undersigned’s knowledge and belief I certify that the information set forth in this statement is true, complete and correct.

    Dated: July 1, 2022

     

    CBG Holdings LLC
    By:  

    /s/ Kenneth W. Metz

    Name:   Kenneth W. Metz
    Title:   President
    Greenstar II LLC
    By:  

    /s/ Oksana S. Dominach

    Name:   Oksana S. Dominach
    Title:   Vice President and Treasurer
    Greenstar II Holdings LLC
    By:  

    /s/ Oksana S. Dominach

    Name:   Oksana S. Dominach
    Title:   Vice President and Treasurer
    Greenstar Canada Investment Limited Partnership
    By:   Greenstar Canada Investment Corporation, its general partner
    By:  

    /s/ Kenneth W. Metz

    Name:   Kenneth W. Metz
    Title:   President
    Greenstar Canada Investment Corporation
    By:  

    /s/ Kenneth W. Metz

    Name:   Kenneth W. Metz
    Title:   President
    Constellation Brands Canada Holdings ULC
    By:  

    /s/ Kenneth W. Metz

    Name:   Kenneth W. Metz
    Title:   President
    Constellation Capital LLC
    By:  

    /s/ Oksana S. Dominach

    Name:   Oksana S. Dominach
    Title:   Vice President and Treasurer


    Constellation International Holdings Limited
    By:  

    /s/ Oksana S. Dominach

    Name:   Oksana S. Dominach
    Title:   Vice President and Treasurer
    Constellation Brands, Inc.
    By:  

    /s/ James O. Bourdeau

    Name:   James O. Bourdeau
    Title:   Executive Vice President, Chief Legal Officer and Secretary


    Annex A

    The following is a list, as of June 30, 2022, of the executive officers and directors of each of CBG Holdings LLC, Greenstar II LLC, Greenstar II Holdings LLC, Greenstar Canada Investment Corporation, Constellation Brands Canada Holdings ULC, Constellation Capital LLC, Constellation International Holdings Limited and Constellation Brands, Inc. (collectively, the “Covered Persons”), setting forth the present principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted and citizenship for each such person. Each Covered Person is a citizen of the United States, unless otherwise noted, and does not have any other principal occupation (outside of similar positions held with respect to other entities directly or indirectly affiliated with Constellation Brands, Inc.) unless otherwise noted.

    Executive Officers of CBG Holdings LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Kenneth W. Metz    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Jeffrey H. LaBarge    Vice President and Assistant Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US
    Barbara J. LaVerdi    Secretary and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of CBG Holdings LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US

    Executive Officers of Greenstar II LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Garth Hankinson    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Jeffrey H. LaBarge    Vice President and Assistant Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US
    Barbara J. LaVerdi    Secretary and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US


    Directors of Greenstar II LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Garth Hankinson    Executive Vice President and Chief Financial Officer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Senior Vice President and Treasurer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US

    Executive Officers of Greenstar II Holdings LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Garth Hankinson    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Jeffrey H. LaBarge    Vice President and Assistant Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US
    Barbara J. LaVerdi    Secretary and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of Greenstar II Holdings LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Garth Hankinson    Executive Vice President and Chief Financial Officer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Senior Vice President and Treasurer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US


    Executive Officers of Greenstar Canada Investment Corporation:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Kenneth W. Metz    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Brian S. Bennett    Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of Greenstar Canada Investment Corporation:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Senior Vice President and Controller of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Senior Vice President and Treasurer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US

    Executive Officers of Constellation Brands Canada Holdings ULC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Kenneth W. Metz    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Brian S. Bennett    Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US


    Directors of Constellation Brands Canada Holdings ULC:

     

    Name

      

    Principal Occupation or Employment

      

    Business Address

      

    Citizenship

    Oksana S. Dominach    Senior Vice President and Treasurer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President, Tax of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US

    Executive Officers of Constellation Capital LLC:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    Garth Hankinson    President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Barbara J. LaVerdi    Secretary and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of Constellation Capital LLC:

     

    Name

      

    Principal Occupation or Employment

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Garth Hankinson    Executive Vice President and Chief Financial Officer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US


    Executive Officers of Constellation International Holdings Limited:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    James A. Sabia, Jr.    President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Garth Hankinson    Executive Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Robert L. Hanson    Executive Vice President    101 Mission Street, San Francisco, California 94105    US
    Michael Becka    Vice President    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Oksana S. Dominach    Vice President and Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Thomas M. McCorry    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Kenneth W. Metz    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Michael Reitz    Vice President and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US
    Timothy D. Robins    Vice President    207 High Point Drive, Building 100, Victor, New York 14564    US
    Barbara J. LaVerdi    Secretary and Assistant Treasurer    207 High Point Drive, Building 100, Victor, New York 14564    US

    Directors of Constellation International Holdings Limited:

     

    Name

      

    Principal Occupation or Employment

      

    Business Address

      

    Citizenship

    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    James A. Sabia, Jr.    Executive Vice President and President, Beer Division of Constellation Brands, Inc.    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Garth Hankinson    Executive Vice President and Chief Financial Officer of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US


    Executive Officers of Constellation Brands, Inc.:

     

    Name

      

    Position

      

    Business Address

      

    Citizenship

    William A. Newlands    President and Chief Executive Officer    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Robert Sands    Executive Chairman of the Board    207 High Point Drive, Building 100, Victor, New York 14564    US
    Richard Sands    Executive Vice Chairman of the Board    207 High Point Drive, Building 100, Victor, New York 14564    US
    Garth Hankinson    Executive Vice President and Chief Financial Officer    207 High Point Drive, Building 100, Victor, New York 14564    US
    James O. Bourdeau    Executive Vice President, Chief Legal Officer and Secretary    207 High Point Drive, Building 100, Victor, New York 14564    US
    K. Kristann Carey    Executive Vice President and Chief Human Resources Officer    131 S. Dearborn Street, Chicago, Illinois 60603    US
    James A. Sabia, Jr.    Executive Vice President and President, Beer Division    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Robert L. Hanson    Executive Vice President and President, Wine & Spirits Division    101 Mission Street, San Francisco, California 94105    US
    Michael McGrew    Executive Vice President and Chief Communications, CSR and Diversity Officer    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Mallika Monteiro    Executive Vice President and Chief Growth, Strategy and Digital Officer    131 S. Dearborn Street, Chicago, Illinois 60603    US


    Directors of Constellation Brands, Inc.:

     

    Name

      

    Principal Occupation or Employment

      

    Business Address

      

    Citizenship

    Christy Clark    Senior Advisor, Bennett Jones LLP    207 High Point Drive, Building 100, Victor, New York 14564    Canada
    Jennifer M. Daniels    Chief Legal Officer and Secretary of Colgate-Palmolive Company    207 High Point Drive, Building 100, Victor, New York 14564    US
    Nicholas I. Fink    Chief Executive Officer of Fortune Brands Home & Security, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Jeremy S. G. Fowden    Chairman of the Board of Primo Water Corporation    207 High Point Drive, Building 100, Victor, New York 14564    United Kingdom
    Ernesto M. Hernandez    Former President and Managing Director of General Motors de Mexico, S. de R.L. de C.V.    207 High Point Drive, Building 100, Victor, New York 14564    Mexico
    Susan Somersille Johnson    Chief Marketing Officer of Prudential, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    James A. Locke III    Senior Counsel to the law firm of Nixon Peabody LLP    207 High Point Drive, Building 100, Victor, New York 14564    US
    Daniel J. McCarthy    Former President and Chief Executive Officer of Frontier Communications Corporation    207 High Point Drive, Building 100, Victor, New York 14564    US
    Jose Manuel Madero Garza    Independent Business Consultant and Former Chief Executive Officer of Grupo Bepensa    207 High Point Drive, Building 100, Victor, New York 14564    Mexico
    William A. Newlands    President and Chief Executive Officer of Constellation Brands, Inc.    131 S. Dearborn Street, Chicago, Illinois 60603    US
    Richard Sands    Executive Vice Chairman of the Board of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Robert Sands    Executive Chairman of the Board of Constellation Brands, Inc.    207 High Point Drive, Building 100, Victor, New York 14564    US
    Judy A. Schmeling    Former Chief Operating Officer of HSN, Inc., and former President of HSN’s Cornerstone Brands    207 High Point Drive, Building 100, Victor, New York 14564    US

     

    Get the next $CGC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CGC

    DatePrice TargetRatingAnalyst
    4/4/2023Underperform → Mkt Perform
    Bernstein
    11/2/2022$1.50Underperform
    Bernstein
    10/26/2022Sell → Hold
    Canaccord Genuity
    6/8/2022Market Perform → Underperform
    BMO Capital Markets
    3/22/2022Equal Weight → Underweight
    Barclays
    3/1/2022$14.00 → $9.00Equal-Weight
    Barclays
    2/18/2022$9.60 → $11.00Neutral
    Cantor Fitzgerald
    12/22/2021Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CGC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Canopy Growth Drives Innovation in High-Demand Segments With Latest Product Launches

      Offerings reflect a focused format strategy in Canada's adult-use market Vapes, high-THC flower, pre-roll joints, and edibles introduced across core brands Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched a series of product innovations targeting Canada's fastest-growing adult-use categories.1 The lineup reflects a focused strategy built around four high-demand formats: vapes, high-THC flower, pre-rolls (including infused), and edibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20

      5/6/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

      New Brand Features Premium Genetics, Selected for Potency, Terpenes, and Consistency Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Spectrum Reserve, a new premium medical cannabis brand in Canada. Designed to meet the evolving needs of medical cannabis patients, Spectrum Reserve represents the peak of cannabis cultivation – featuring flower selected for size, potency, and terpene levels through rigorous in-house standards during cultivation and post-harvest. Under this new program, Spectrum Reserve is expected to introduce new strains on a r

      4/2/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Strengthens Balance Sheet with Optional Early Prepayment to Reduce Term Loan by US$100 Million

      Early Prepayment Reduces Annual Interest Expense by US$13 Million, Extends Maturity of Term Loan to September 2027 This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated June 6, 2024 to its short form base shelf prospectus dated February 28, 2025 Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that it has made an optional early prepayment under its senior secured term loan (the "Term Loan") in an aggregate principal amount equal to US$100 million at a discounted price of US

      4/1/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    SEC Filings

    See more
    • Canopy Growth Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Canopy Growth Corp (0001737927) (Filer)

      4/1/25 7:54:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Canopy Growth Corp (0001737927) (Filer)

      2/28/25 5:19:22 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 424B5 filed by Canopy Growth Corporation

      424B5 - Canopy Growth Corp (0001737927) (Filer)

      2/28/25 5:17:50 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

      SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

      4/19/24 5:00:49 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

      SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

      11/3/23 4:30:53 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13D/A filed by Canopy Growth Corporation (Amendment)

      SC 13D/A - Canopy Growth Corp (0001737927) (Subject)

      7/20/23 4:35:52 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care

    $CGC
    Financials

    Live finance-specific insights

    See more

    $CGC
    Leadership Updates

    Live Leadership Updates

    See more

    $CGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Week in Canadian Press Releases: 10 Stories You Need to See

      A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, Feb. 14, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that

      2/14/25 6:18:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Reports Third Quarter Fiscal Year 2025 Financial Results

      Strong holiday sales drove Storz & Bickel net revenue growth of 19% year-over-year   Record quarter for Canada medical cannabis with net revenue increasing 16%; international markets cannabis net revenue grew 14% year-over-year    Successfully launched Claybourne infused pre-rolls across Canada, Claybourne rose to #3 market share in the infused pre-roll category in British Columbia and Ontario after 6 weeks in market1 SMITHS FALLS, ON, Feb. 7, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announces its financial results for the third fiscal quarter ended December 31, 2024 ("Q3 FY2025"). All financial information in this press

      2/7/25 7:00:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth to Report Third Quarter Fiscal 2025 Financial Results on February 7, 2025

      SMITHS FALLS, ON, Jan. 24, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2025 ended December 31, 2024 before financial markets open on February 7, 2025. Following the release of its third quarter fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Judy Hong, CFO on February 7 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://app.webinar.net/yY1K7LrWq9O

      1/24/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President

      A cannabis and beverage alcohol industry executive with more than 25 years of experience, Mr. Jorgensen will lead the unified Canopy USA organization forward with a focus on driving profitable growth across the U.S. With the completed acquisitions of Acreage, Wana, and Jetty, Canopy USA now enters a new chapter of growth across key segments including flower, edibles, vapes, extracts, and through an established retail presence in high potential markets across the Midwest and Northeast BOULDER, Colo., January 6, 2025 /PRNewswire/ - Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the fastest growing states and highest potential segments of the U.S. c

      1/6/25 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Announces Results of Annual General Meeting

      SMITHS FALLS, ON, Sept. 25, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) is pleased to announce today the voting results from its annual general meeting of shareholders held on September 24, 2024 (the "Meeting"). All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 1, 2024 (the "Proxy Statement"), were approved by the requisite number of votes cast at the Meeting, as further detailed below. Each of the direc

      9/25/24 7:30:00 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth Announces Extension of Proxy Voting Deadline for Upcoming Annual General Meeting

      Shareholders now have until September 24, 2024 at 9:00 a.m. (Eastern Time) to submit votes to help ensure a quorum is achieved Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail at [email protected] SMITHS FALLS, ON, Sept. 20, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) announced today that it has extended the deadline for the submission of proxies related to its upcoming annual general meeting of shareholders (the "Meeting") to September 24, 2024 at 9:00 a.m. (Eastern time). The Meeting will be held later the same day, at 1:00 p.m.

      9/20/24 4:45:00 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Yanofsky Theresa sold $1,844 worth of shares (2,004 units at $0.92), decreasing direct ownership by 9% to 20,199 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      4/2/25 4:17:13 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lazzarato David Angelo sold $2,764 worth of shares (3,004 units at $0.92), decreasing direct ownership by 12% to 22,886 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      4/2/25 4:16:37 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Kruh Willy sold $1,851 worth of shares (2,012 units at $0.92), decreasing direct ownership by 18% to 9,272 units (SEC Form 4)

      4 - Canopy Growth Corp (0001737927) (Issuer)

      4/2/25 4:15:15 PM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth upgraded by Bernstein

      Bernstein upgraded Canopy Growth from Underperform to Mkt Perform

      4/4/23 9:09:41 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Bernstein initiated coverage on Canopy Growth with a new price target

      Bernstein initiated coverage of Canopy Growth with a rating of Underperform and set a new price target of $1.50

      11/2/22 6:11:10 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care
    • Canopy Growth upgraded by Canaccord Genuity

      Canaccord Genuity upgraded Canopy Growth from Sell to Hold

      10/26/22 7:36:52 AM ET
      $CGC
      Medicinal Chemicals and Botanical Products
      Health Care